Insider · CIK 0001771961
Alexander Azoy
officer
Files at RCUS (Arcus Biosciences, Inc.). First filing Dec 4, 2024, latest Dec 18, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 5
$0 bought, $303k sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
RCUS: Arcus Biosciences, Inc.
RCUSOct 9, 2026 · close 24.41
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 32Weak | Arcus Biosciences, Inc. | $195k 8,832 shares | -32% | +223% from low-15% from high | |
| 2Weak | Arcus Biosciences, Inc. | $49k 1,900 shares | -6% | +272% from low0% from high | |
| 9Weak | Arcus Biosciences, Inc. | $37k 2,831 shares | -9% | +94% from low-28% from high | |
| 0Weak | Arcus Biosciences, Inc. | $19k 1,579 shares | -5% | +77% from low-34% from high | |
| 0Weak | Arcus Biosciences, Inc. | $3,079 201 shares | -1% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 16, 2025 | RCUS Arcus Biosciences, Inc. | SOpen-market sale Common Stock10b5-1 | -2,376 | $21.88 | $52k | 24,987 | Dec 18, 2025 |
| Dec 17, 2025 | RCUS Arcus Biosciences, Inc. | SOpen-market sale Common Stock10b5-1 | -2,113 | $22.16 | $47k | 22,874 | Dec 18, 2025 |
| Dec 18, 2025 | RCUS Arcus Biosciences, Inc. | SOpen-market sale Common Stock10b5-1 | -4,343 | $22.25 | $97k | 18,531 | Dec 18, 2025 |
| Nov 26, 2025 | RCUS Arcus Biosciences, Inc. | MOption exercise Common Stock10b5-1 | +1,900 | $13.33 | $25k | 29,263 | Dec 1, 2025 |
| Nov 26, 2025 | RCUS Arcus Biosciences, Inc. | SOpen-market sale Common Stock10b5-1 | -1,900 | $26.00 | $49k | 27,363 | Dec 1, 2025 |
| Nov 26, 2025 | RCUS Arcus Biosciences, Inc. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -1,900 | $0.00 | $0 | 9,500 | Dec 1, 2025 |
| Sep 29, 2025 | RCUS Arcus Biosciences, Inc. | SOpen-market sale Common Stock10b5-1 | -2,831 | $13.00 | $37k | 27,363 | Sep 30, 2025 |
| Sep 5, 2025 | RCUS Arcus Biosciences, Inc. | SOpen-market sale Common Stock10b5-1 | -1,579 | $11.88 | $19k | 30,194 | Sep 5, 2025 |
| Jan 23, 2025 | RCUS Arcus Biosciences, Inc. | AGrant or award Common Stock | +17,100 | $0.00 | $0 | 30,194 | Jan 27, 2025 |
| Jan 23, 2025 | RCUS Arcus Biosciences, Inc. | AGrant or award Stock Option (right to buy)derivative | +11,400 | $0.00 | $0 | 11,400 | Jan 27, 2025 |
| Dec 19, 2024 | RCUS Arcus Biosciences, Inc. | DDisposition to issuer Common Stock10b5-1 | -3,007 | $15.17 | $46k | 13,094 | Dec 20, 2024 |
| Dec 15, 2024 | RCUS Arcus Biosciences, Inc. | FTax withholding Common Stock | -2,969 | $16.08 | $48k | 16,101 | Dec 17, 2024 |
| Dec 2, 2024 | RCUS Arcus Biosciences, Inc. | SOpen-market sale Common Stock10b5-1 | -201 | $15.32 | $3,079 | 19,070 | Dec 4, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.